The Horizon Europe-funded ASCERTAIN project aims to develop new pricing, cost-effectiveness, and reimbursement models that balance incentives for developing new and effective health technologies with sustainable patient access. A key component of the project is the development of...
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
ASCERTAIN: Progress in developing new models for improving access to innovative health technologies
Launch of the AUGMENT Biosimilars Knowledge Hub
The Pharmacoeconomics Department leads the AUGMENT Consortium who was commissioned by the European Health and Digital Executive Agency (HaDEA) to conduct the project “Capacity building to support the uptake of biosimilars in a multistakeholder approach”. A stakeholder network for...
Looking back at the Vienna Winter School for public authorities on implementing pharmaceutical pricing and reimbursement policies
The Vienna Winter School on pharmaceutical pricing and reimbursement policies took place from 18-21 February 2025 at the Austrian National Public Health Institute (Gesundheit Österreich GmbH). It was the seventh School organised by the Pharmacoeconomics Department and brought...